Inhibiting FANCM-TOP3A-RMI1 interaction for osteosarcoma, Lesch-Nyhan syndrome

DISEASE CATEGORY: Cancer; endocrine/metabolic

INDICATION: Bone cancer; metabolic

Cell culture studies suggest inhibiting the FANCM-TOP3A-RMI1 interaction

Read the full 144 word article

User Sign In